Correlation Between Vaccinex and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Citius Oncology,, you can compare the effects of market volatilities on Vaccinex and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Citius Oncology,.
Diversification Opportunities for Vaccinex and Citius Oncology,
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Vaccinex and Citius is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Vaccinex i.e., Vaccinex and Citius Oncology, go up and down completely randomly.
Pair Corralation between Vaccinex and Citius Oncology,
Given the investment horizon of 90 days Vaccinex is expected to generate 1.16 times more return on investment than Citius Oncology,. However, Vaccinex is 1.16 times more volatile than Citius Oncology,. It trades about 0.03 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.11 per unit of risk. If you would invest 379.00 in Vaccinex on August 30, 2024 and sell it today you would lose (10.00) from holding Vaccinex or give up 2.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vaccinex vs. Citius Oncology,
Performance |
| Timeline |
| Vaccinex |
| Citius Oncology, |
Vaccinex and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vaccinex and Citius Oncology,
The main advantage of trading using opposite Vaccinex and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Vaccinex vs. Protara Therapeutics | Vaccinex vs. Monopar Therapeutics | Vaccinex vs. Surrozen | Vaccinex vs. Salarius Pharmaceuticals |
| Citius Oncology, vs. Phibro Animal Health | Citius Oncology, vs. Procaps Group SA | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |